[HTML][HTML] Endorobots for colonoscopy: Design challenges and available technologies
L Manfredi - Frontiers in Robotics and AI, 2021 - frontiersin.org
Colorectal cancer (CRC) is the second most common cause of cancer death worldwide, after
lung cancer. Early stage detection is key to increase the survival rate. Colonoscopy remains …
lung cancer. Early stage detection is key to increase the survival rate. Colonoscopy remains …
Research on the economics of cancer-related health care: an overview of the review literature
AJ Davidoff, K Akif, MT Halpern - JNCI Monographs, 2022 - academic.oup.com
We reviewed current literature reviews regarding economics of cancer-related health care to
identify focus areas and gaps. We searched PubMed for systematic and other reviews with …
identify focus areas and gaps. We searched PubMed for systematic and other reviews with …
Is there a place for sigmoidoscopy in colorectal cancer screening? A systematic review and critical appraisal of cost-effectiveness models
L Diedrich, M Brinkmann, M Dreier, S Rossol… - Plos one, 2023 - journals.plos.org
Introduction Screening for colorectal cancer (CRC) is effective in reducing both incidence
and mortality. Colonoscopy and stool tests are most frequently used for this purpose …
and mortality. Colonoscopy and stool tests are most frequently used for this purpose …
Robotic colonoscopy and beyond: insights into modern lower gastrointestinal endoscopy
E Tumino, P Visaggi, V Bolognesi, L Ceccarelli… - Diagnostics, 2023 - mdpi.com
Lower gastrointestinal endoscopy is considered the gold standard for the diagnosis and
removal of colonic polyps. Delays in colonoscopy following a positive fecal immunochemical …
removal of colonic polyps. Delays in colonoscopy following a positive fecal immunochemical …
Cost-effectiveness of colorectal cancer screening in Slovakia
R Babela, A Orsagh, J Ricova… - European Journal of …, 2022 - journals.lww.com
Background Colorectal cancer (CRC) is an ideal disease for screening due to known and
detectable precursor lesions and slow progression from benign adenoma to invasive …
detectable precursor lesions and slow progression from benign adenoma to invasive …
Evaluating the predictive performance of gut microbiota for the early-stage colorectal cancer
M Amini, S Rezasoltani, MA Pourhoseingholi… - BMC …, 2022 - Springer
Background Colorectal cancer (CRC) has been regarded as one of the most frequently
diagnosed malignancies among the leading causes of cancer-related morbidity and …
diagnosed malignancies among the leading causes of cancer-related morbidity and …
Test de sangre oculta en deposiciones para programas de cribado de cáncer colorrectal: actualización
AM Wielandt, C Hurtado, M Moreno, A Zárate… - Revista médica de …, 2021 - SciELO Chile
Test de sangre oculta en deposiciones para programas de cribado de cáncer colorrectal:
actualización SciELO - Scientific Electronic Library Online vol.149 número4 Rol de la microbiota …
actualización SciELO - Scientific Electronic Library Online vol.149 número4 Rol de la microbiota …
Modeling costs and benefits of the organized colorectal cancer screening programme and its potential future improvements in Hungary
Objective The national population-based colorectal cancer screening programme in
Hungary was initiated in December 2018. We aimed to evaluate the current programme and …
Hungary was initiated in December 2018. We aimed to evaluate the current programme and …
[HTML][HTML] Impact of colorectal cancer screening participation in remote northern Canada: A retrospective cohort study
HA Smith, AD Scarffe, N Brunet… - World Journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Screening provides earlier colorectal cancer (CRC) detection and improves
outcomes. It remains poorly understood if these benefits are realized with screening …
outcomes. It remains poorly understood if these benefits are realized with screening …
Cost-effectiveness of colorectal cancer genetic testing
AR Ramdzan, MRA Manaf, AN Aizuddin… - International journal of …, 2021 - mdpi.com
Colorectal cancer (CRC) remains the second leading cause of cancer-related deaths
worldwide. Approximately 3–5% of CRCs are associated with hereditary cancer syndromes …
worldwide. Approximately 3–5% of CRCs are associated with hereditary cancer syndromes …